Form 4 for DVA DaVita
Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-26 · accession 0000927066-24-000028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-28 | 2024-02-26+ | DVA | Rodriguez Javier | CEO, Dir | M - OptEx | $67.80 | +500.0K | 889.0K | +129% | +$33.90M |
| DM | 2024-02-28 | 2024-02-26+ | DVA | Rodriguez Javier | CEO, Dir | D - Sale to Iss | $125.49 | -270.1K | 504.7K | -35% | -$33.90M |
| DM | 2024-02-28 | 2024-02-26+ | DVA | Rodriguez Javier | CEO, Dir | S - Sale+OE | $126.18 | -75.0K | 481.3K | -13% | -$9.46M |
| DM | 2024-02-28 | 2024-02-26+ | DVA | Rodriguez Javier | CEO, Dir | F - Tax | $125.50 | -99.4K | 494.5K | -17% | -$12.47M |
| DM | 2024-02-28 | 2024-02-26+ | DVA | Rodriguez Javier | CEO, Dir | M - OptEx | $0.00 | -500.0K | 1.55M | -24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | M | A | 50,000 | $67.80 | 531,300 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-26 | D | D | 243,574 | $125.26 | 645,428 | D | — | — | (F1) Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. |
| 3 | Common | Common Stock | 2024-02-26 | S | D | 67,603 | $126.11 | 488,697 | D | — | — | (F3) Represents the weighted average sale price of $126.1058. The range of prices for the sale of these shares was $125.90- $126.76 rounded to the nearest tenth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-02-27 | S | D | 7,397 | $126.87 | 481,300 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-26 | F | D | 89,128 | $125.26 | 556,300 | D | — | — | (F2) Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. |
| 6 | Common | Common Stock | 2024-02-28 | D | D | 26,568 | $127.60 | 504,732 | D | — | — | (F1) Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. |
| 7 | Common | Common Stock | 2024-02-28 | F | D | 10,252 | $127.60 | 494,480 | D | — | — | (F2) Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. |
| 8 | Common | Common Stock | 2024-02-26 | M | A | 450,000 | $67.80 | 889,002 | D | — | — | |
| 9 | Derivative | Stock Appreciation Rights | 2024-02-28 | M | D | 50,000 | $0.00 | 1,500,000 | D | $67.80 · 2022-11-04 to 2024-11-04 | 50,000 Common Stock | (F4) This award was approved by the Compensation Committee of DaVita's Board of Directors on November 4, 2019, subject to stockholder approval to amend its 2011 Incentive Award Plan ("Plan Amendment"). DaVita's stockholder's approved the Plan Amendment on January 23, 2020. This award vested 50% each on November 4, 2022 and November 4, 2023. |
| 10 | Derivative | Stock Appreciation Rights | 2024-02-26 | M | D | 450,000 | $0.00 | 1,550,000 | D | $67.80 · 2022-11-04 to 2024-11-04 | 450,000 Common Stock | (F4) This award was approved by the Compensation Committee of DaVita's Board of Directors on November 4, 2019, subject to stockholder approval to amend its 2011 Incentive Award Plan ("Plan Amendment"). DaVita's stockholder's approved the Plan Amendment on January 23, 2020. This award vested 50% each on November 4, 2022 and November 4, 2023. |